A randomized trial of temazepam versus acetazolamide in high altitude sleep disturbance. 2013

John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
1 Division of Wilderness Medicine, Department of Emergency Medicine, Massachusetts General Hospital , Boston, Massachusetts.

This study is the first comparative trial of sleep medications at high altitude. We performed a randomized, double-blind trial of temazepam and acetazolamide at an altitude of 3540 meters. 34 healthy trekkers with self-reports of high-altitude sleep disturbance were randomized to temazepam 7.5 mg or acetazolamide 125 mg taken at bedtime for one night. The primary outcome was sleep quality on a 100 mm visual analog scale. Additional measurements were obtained with actigraphy; pulse oximetry; and questionnaire evaluation of sleep, daytime drowsiness, daytime sleepiness, and acute mountain sickness. Sixteen subjects were randomized to temazepam and 18 to acetazolamide. Sleep quality on the 100 mm visual analog scale was higher for temazepam (59.6, SD 20.1) than acetazolamide (46.2, SD 20.2; p=0.048). Temazepam also demonstrated higher subjective sleep quality on the Groningen Sleep Quality Scale (3.5 vs. 6.8, p=0.009) and sleep depth visual analog scale (60.3 vs. 41.4, p=0.028). The acetazolamide group reported significantly more awakenings to urinate (1.8 vs. 0.5, p=0.007). No difference was found with regards to mean nocturnal oxygen saturation (84.1 vs. 84.4, p=0.57), proportion of the night spent in periodic breathing, relative desaturations, sleep onset latency, awakenings, wake after sleep onset, sleep efficiency, Stanford Sleepiness Scale scores, daytime drowsiness, or change in self-reported Lake Louise Acute Mountain Sickness scores. We conclude that, at current recommended dosing, treatment of high-altitude sleep disturbance with temazepam is associated with increased subjective sleep quality compared to acetazolamide.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086 Acetazolamide One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337) Acetadiazol,Acetazolam,Acetazolamide Sodium, (Sterile),Acetazolamide, Monosodium Salt,Ak-Zol,Apo-Acetazolamide,Diacarb,Diamox,Diuramide,Défiltran,Edemox,Glauconox,Glaupax,Huma-Zolamide,Ak Zol,AkZol,Apo Acetazolamide,ApoAcetazolamide,Huma Zolamide,HumaZolamide

Related Publications

John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
April 1987, The American review of respiratory disease,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
January 1982, Current medical research and opinion,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
January 2022, Frontiers in physiology,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
January 2012, Journal of travel medicine,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
December 1979, The New England journal of medicine,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
January 1981, The Journal of international medical research,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
February 1998, BMJ (Clinical research ed.),
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
September 2010, Wilderness & environmental medicine,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
November 2012, Current opinion in pulmonary medicine,
John B Tanner, and Sarah M E Tanner, and Ghan Bahadur Thapa, and Yuchiao Chang, and Kirsty L M Watson, and Eamon Staunton, and Claire Howarth, and Buddha Basnyat, and N Stuart Harris
January 2004, The European respiratory journal,
Copied contents to your clipboard!